Key facts
- Chongqing Porton Pharmaceutical Technology (SHE: 300363) is a other based in Chongqing, China.
About Chongqing Porton Pharmaceutical Technology (SHE: 300363)
Chongqing Porton Pharmaceutical Technology is a corporation based in. Established in 2005, the company provides end-to-end CDMO and CRO services for small molecules, peptides, oligonucleotides, biologics, conjugates (ADCs, AOCs, PDCs), and advanced therapy medicinal products. Its offerings span cell banking, process and analytical development, GMP manufacturing, testing, and fill-finish across preclinical to commercial stages. The assets are managed by the executive management team.
Free account
See more of the book
- ·Watchlist + alerts for Chongqing Porton Pharmaceutical Technology (SHE: 300363)'s activity
Create free account
No card required
Portfolio
Portfolio — not yet on record
No portfolio companies for Chongqing Porton Pharmaceutical Technology (SHE: 300363) are on record yet. Positions surface from round participations, filings, and coverage.
Pro members can request priority coverage with a 48-hour turnaround.